Yoshiaki Tomiyama
Overview
Explore the profile of Yoshiaki Tomiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
1694
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuwana M, Tomiyama Y
Int J Hematol
. 2025 Jan;
121(3):356-362.
PMID: 39873866
Fostamatinib had superior efficacy to a placebo and acceptable safety profiles for at least 1 year in a phase 3 study of Japanese patients with primary immune thrombocytopenia. Here, we...
2.
Zaimoku Y, Sakai K, Tsuji N, Hosomichi K, Yamada S, Tran D, et al.
Br J Haematol
. 2024 Aug;
205(5):1995-1999.
PMID: 39155468
We describe the case of a 74-year-old man with severe aplastic anaemia who experienced persistent remission attributed to proliferation of HLA allele-deficient clones. Despite an initial worsening of pancytopenia with...
3.
Tabata S, Hosoi H, Wan K, Sakaki A, Mushino T, Murata S, et al.
Br J Haematol
. 2024 Mar;
204(5):1953-1957.
PMID: 38522847
Immune thrombocytopenia (ITP) is characterized by early platelet destruction and impaired platelet production. Helicobacter pylori (H. pylori) infection seems to contribute to the pathogenesis in certain ITP patients in Japan....
4.
Kuwana M, Ito T, Kowata S, Hatta Y, Fujimaki K, Naito K, et al.
Am J Hematol
. 2024 Jan;
99(2):E55-E59.
PMID: 38165064
No abstract available.
5.
Mitani K, Lee J, Jang J, Tomiyama Y, Miyazaki K, Nagafuji K, et al.
Blood Adv
. 2023 Dec;
8(6):1415-1419.
PMID: 38134300
No abstract available.
6.
Kashiwagi H, Kuwana M, Murata M, Shimada N, Takafuta T, Yamanouchi J, et al.
Int J Hematol
. 2023 Nov;
119(1):1-13.
PMID: 37957517
Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia due to accelerated platelet destruction and impaired platelet production. Diagnosis of ITP is still challenging because ITP has...
7.
Kiyokawa T, Mimura K, Nagamine K, Nakayama K, Horiuchi M, Morikawa T, et al.
Int J Hematol
. 2023 Feb;
118(1):146-150.
PMID: 36797397
Background: Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is caused by anti-HPA alloantibody, and anti-HPA-4b is the most common cause in Japanese. Anti-HPA-5b is frequently detected in pregnant women, but it...
8.
Kuwana M, Ito T, Kowata S, Hatta Y, Fujimaki K, Naito K, et al.
Br J Haematol
. 2022 Dec;
200(6):802-811.
PMID: 36470677
Fostamatinib, a spleen tyrosine kinase inhibitor, has been approved for the treatment of chronic primary immune thrombocytopenia (ITP) in the United States, Canada and some European countries. We conducted a...
9.
Matsuda A, Imada K, Obara N, Iida H, Yamazaki H, Tomiyama Y, et al.
Am J Clin Pathol
. 2022 Aug;
158(5):604-615.
PMID: 36018052
Objectives: Eltrombopag, a thrombopoietin-receptor agonist, stimulates hematopoiesis in patients with acquired aplastic anemia (AA). Cytomorphologic changes in bone marrow after eltrombopag administration are still unclear. This study examined the effect...
10.
Tomiyama Y, Cheze S, Grant L, Bonner N, Affinito S, Nagano M, et al.
Int J Hematol
. 2022 Jun;
116(4):500-527.
PMID: 35675024
Objectives: The Immune Thrombocytopenia (ITP) Life Quality Index (ILQI) is a 10-item patient-reported outcome (PRO) measure developed in US-English to assess health-related quality of life (HRQoL) of adults with ITP....